
Science Resources RSS Feeds
|
 |
 |
 |
USC researchers identify DNA mutation that occurs at beginning point of T-cell lymphoma
June 12, 2009
Researchers at the Keck School of Medicine of the University of Southern California (USC) have identified a key mechanism that causes chromosomes within blood cells to break-an occurrence that marks the first step in the development of human lymphoma. The study provides researchers with the clearest insight yet into why these breakages-called chromosomal translocations-occur at a specific points in the chromosome, says principal investigator Michael R. Lieber, M.D., Ph.D., Rita and Edward Polusky Professor in Basic Cancer Research at the Keck School of Medicine.
The study appears as the featured cover article in the June 12 issue of the journal Molecular Cell. The study is the second led by Lieber to appear on the cover of a Cell journal in the past six months.
"The new findings go to the heart of why cancers begin. This is an opportunity to see the very beginning step of human lymphoma," Lieber says. "With this information, we can now begin to look at ways to interfere with this process in order to stop the lymphoma and to develop more targeted therapies for treatment."
There are two types of lymphoma: B cell lymphomas and T cell lymphomas. Both B cells and T cells perform vital functions in the immune system by creating antibodies and destroying virus-infected cells. However, the beginning point, or inception, of most human lymphomas occurs when two chromosomes break and the resulting fragments are reassembled in an exchange.
Researchers specifically looked at T cell acute lymphoblastic lymphomas (ALL). ALL accounts for half of all childhood cancers under the age of five, and T cell ALL represents about 10 percent of ALL. The USC scientists identified a specific enzyme known as the RAG complex that occasionally cuts the chromosome at an off-target site, causing lymphocyte (blood) cells to proliferate uncontrollably.
They showed that the RAG complex selects the wrong target largely because the proteins in which the wrong chromosome is wrapped (called chromatin) lures the RAG complex to the wrong site.
"The immune system is very good at its job," Lieber says. "More than ninety-nine percent of the time it gets it right, but it only takes one mistake in one of a hundred million cells to cause a problem. "
The paper follows a similar study, published in the December issue of the journal Cell, in which Lieber and colleagues determined how the most common chromosomal translocation in B cell lymphoma occurs. Researchers at USC have been working for many years to understand the underlying mechanisms that cause blood cancers.
"The goal is to understand translocations in various different forms of lymphoma," Lieber says. "The two papers cover more than half of all human lymphomas. That represents a major step forward in understanding this disease."
University of Southern California
|
 |
Related Lymphoma Current Events and Lymphoma News Articles Lymphoma Current Events and Lymphoma News RSS Drugs to treat anemia in cancer patients linked to thromboembolism Medications frequently given to cancer patients to reduce their risk of anemia are associated with an increased risk of deep vein thrombosis or pulmonary embolism, according to new research led by Dawn Hershman, M.D, M.S., co-director of the breast cancer program at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center.
Researchers find new way to attack inflammation in Graves' eye disease A small group of patients with severe Graves' eye disease experienced rapid improvement of their symptoms - and improved vision - following treatment with the drug rituximab.
Approved lymphoma drug shows promise in early tests against bone cancer A drug already approved for the treatment of lymphoma may also slow the growth of the most deadly bone cancer in children and teens, according to an early-stage study published online today in the International Journal of Cancer.
Immunotherapy demonstrates long-term success in treating lymphoma Targeted immunotherapy has been an attractive new therapeutic area for a number of cancers because it has the potential to destroy tumor cells without damaging surrounding normal tissue. New study results demonstrate high success rates using specialized white blood cells to prevent or treat lymphoma associated with the Epstein-Barr virus (EBV-lymphoma) in patients who have received a hematopoietic stem cell transplant (HSCT).
Exercise is good medicine for lymphoma patients A healthy dose of exercise is good medicine, even for lymphoma patients receiving chemotherapy, University of Alberta researchers have found.
Childhood cancer survivors experience suicidal thoughts decades after diagnosis Adult survivors of childhood cancer have an increased risk for suicidal thoughts, even decades after their cancer treatments ended, according to a study led by Dana-Farber Cancer Institute scientists.
New therapy for vasculitis will help patients avoid infertility and cancer Researchers have identified that Rituxan, a drug previously approved for the treatment of non-Hodgkin's B cell lymphoma and rheumatoid arthritis, can treat severe ANCA-associated vasculitis as effectively as cyclophosphamide, the current standard therapy.
Studying cancer in pet dogs to find new treatments for human patients A team of scientists at the National Cancer Institute (NCI) in Bethesda, USA, says that studying pet dogs with cancer could yield valuable information on how to diagnose and treat human cancers.
Scientists identify genetic cause of previously undefined primary immune deficiency disease Researchers at the National Institutes of Health have identified a genetic mutation that accounts for a perplexing condition found in people with an inherited immunodeficiency.
Certain cancers more common among HIV patients than non-HIV patients Researchers at UT Southwestern Medical Center have found that non-AIDS-defining malignancies such as anal and lung cancer have become more prevalent among HIV-infected patients than non-HIV patients since the introduction of anti-retroviral therapies in the mid-1990s. More Lymphoma Current Events and Lymphoma News Articles
|
 |

|
Living with Lymphoma: A Patient's Guide
by Elizabeth M. Adler PhD (Author)
"Adler's professional background and experience as a lymphoma survivor make her the perfect person to write this book. The author's explanations are a gentle guide and a thorough introduction to the basics that give us the confidence to handle decisions relating to treatments and other aspects of lymphoma." -- Anne Atkinson, non-Hodgkin lymphoma and Hodgkin disease survivor and coordinator of the Women's Cancer Group
|

|
Non-Hodgkin Lymphomas
by James O Armitage (Editor), Peter M Mauch (Editor), Nancy Lee Harris (Editor), Bertrand Coiffier (Editor), Riccardo Dalla-Favera (Editor)
Thoroughly updated for its Second Edition, Non-Hodgkin Lymphomas is the definitive textbook on the biology, diagnosis, staging, and treatment of all forms of non-Hodgkin lymphomas. With backgrounds in medical and radiation oncology, molecular biology, and pathology, the editors and contributors provide an international, multidisciplinary approach to the topic. This edition is the first text using the new World Health Organization classification of non-Hodgkin lymphomas. The book offers complete coverage of the most current techniques for diagnosis, staging, and treatment, the approach to specific types of lymphoma, and special problems common to the management of patients with these disorders. A companion Website includes the fully searchable text and downloadable images.
|

|
100 Questions & Answers About Lymphoma
by Peter Holman (Author), Jodi Garrett (Author), William D. Jansen (Author)
This text is a patient-oriented guide to dealing with lymphoma. Questions and answers cover basic questions about the disease such as risk factors and causes; methods of prevention, screening, and diagnosis; available treatments and how to choose among them; and ways of coping with common emotional and physical difficulties associated with the diagnosis and treatment. Dr. Holman is a practicing oncologist, and Ms. Garrett is an oncology nurse; the pair team up to provide both a doctor’s and a caregiver’s perspective in answering these common questions.
|

|
Lymphoma (Fast Facts)
by Chris Hatton (Author), Graham Collins (Author), John, M.D. Sweetenham (Author)
Lymphomas arise from a single abnormal lymphocyte, yet many different subtypes of lymphoma occur. Recent advances in cellular and molecular techniques have revolutionized physicians' understanding of this malignancy, and there have been dramatic developments in diagnosis and treatment. "Fast Facts: Lymphoma" gives a comprehensive and up-to-date perspective on this challenging disease written by three experts in the field. Starting with a clear outline of the nature of lymphoma, its diagnosis, staging and management, this concise handbook goes on to provide specific details of individual lymphoma entities and treatment modalities. "Fast Facts: Lymphoma" is a valuable handbook for training doctors and specialist nurses working in the field of hemato-oncology, and will be of interest to the...
|

|
Hodgkin Lymphoma
by Richard T Hoppe (Editor), Peter M Mauch (Editor), James O Armitage (Editor), Volker Diehl (Editor), Lawrence M Weiss (Editor)
The definitive text on Hodgkin lymphoma is now in its thoroughly revised, updated Second Edition. More than 100 recognized authorities from all parts of the world provide comprehensive, current information on every aspect of Hodgkin lymphoma, including etiology, epidemiology, biology, pathology, evaluation, staging, treatment, and follow-up. This edition describes the increased use of PET scanning in staging and follow-up. Chapters discuss current treatment options—including combination chemotherapy, radiation therapy, novel treatment techniques, and hematopoietic stem cell transplantation—and offer guidelines for treatment selection. Full consideration is given to late effects of therapy and clinical trials for assessing quality of life in patients. This edition includes...
|

|
Handcrafted Artisan Lymphoma Awareness Heart Pendant & Sterling Silver Chain Necklace 412
by Pendant@Joyful-Creations.com
Pendant: Peridot Swarovski Austrian crystal bicones, sterling silver Bali bead cap & daisy spacers, sterling rounds. Crystal AB faceted Czech firepolished glass pear bead and sterling silver round dangle and pendant all handwrapped with sterling silver wire. Pendant drops approx. 2 1/2" and includes a sterling silver bale marked .925 on the back. Focal Bead: White polymer clay heart with beautiful lime green roses all around the heart, handmade by Uiko Ogawa. Show your support for a cure for Lymphoma, Non-Hodgkins Lymphoma, Lyme Disease, Muscular Dystrophy. 18" Sterling silver Italian Singapore chain included in this auction. Singapore chains are so elegant! They have a natural twist in their manufacture and therefore LOTS of sparkle. ** Gift Boxed - Ready for gift giving **
|

|
New Design Green Lymphoma Awareness 8" Car Magnet
by sci
New Design Green Lymphoma Awareness 8" Car Magnet
|

|
Lymphoma Awareness Ribbon Mouse Pad
by MyHeritageWear.com
The Lymphoma Ribbon proudly displayed on a mouse pad. There is no better way to achieve awareness for the meaning of the Lymphoma Ribbon than to display it on your mouse pad for everyone to see. The mouse pad measures at 9.25 x 7.75, it is machine washable, and the colors will not fade or run. Start gaining awareness today by presenting your Lymphoma Ribbon mouse pad at work or at home. It is certain to keep your mouse rolling in style all while gaining support and awareness!
|

|
Hodgkin Lymphoma Hardbound Textbook- Second Edition
by lippincott and williams
The definitive text on Hodgkin lymphoma is now in its thoroughly revised, updated Second Edition. More than 100 recognized authorities from all parts of the world provide comprehensive, current information on every aspect of Hodgkin lymphoma, including etiology, epidemiology, biology, pathology, evaluation, staging, treatment, and follow-up. This edition describes the increased use of PET scanning in staging and follow-up. Chapters discuss current treatment optionsincluding combination chemotherapy, radiation therapy, novel treatment techniques, and hematopoietic stem cell transplantationand offer guidelines for treatment selection. Full consideration is given to late effects of therapy and clinical trials for assessing quality of life in patients. This edition includes complete access...
|
|
|
As Long As I'm Here
by Leukemia & Lymphoma Society Benefit CD
|
|